Clik here to view.
Initiation of Phase 1 Clinical Study with Novel Immuno-Oncology Candidate...
TOKYO Sosei Group Corporation (“Sosei”; TOKYO Mothers Index: 4565) today announces Heptares Therapeutics (“Heptares”), the wholly-owned subsidiary of Sosei Group Corporation, reported that it has...
View ArticleClik here to view.
Takeda Receives European Commission Approval of ADCETRIS® (brentuximab...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Commission (EC) has extended the current conditional marketing authorization...
View ArticleClik here to view.
Cardiovascular Systems Submits Diamondback 360® Coronary Orbital Atherectomy...
ST. PAUL, Minn. Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), today announced that it has submitted an application to Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) for approval of...
View ArticleClik here to view.
ファインデックス、TEAMLAB BODYとの戦略的協業により更なるシェア拡大を図る
東京 （ビジネスワイヤ） — 株式会社ファインデックス（東証一部：3649 本社：東京・愛媛 代表取締役：相原輝夫）は、TEAMLAB BODY株式会社（本社：大阪 代表取締役：西谷剛史）と戦略的協業を行うことに合意いたしました。 本協業では、ファインデックスの画像ファイリングシステム「Claio」とTEAMLAB BODY株式会社の「teamLabBody-3D Motion Human...
View ArticleClik here to view.
欧盟委员会核准武田的ADCETRIS® (brentuximab vedotin)用于移植后霍奇金淋巴瘤巩固治疗
马萨诸塞州剑桥和日本大阪 (美国商业资讯) — 武田药品工业株式会社(TSE: 4502)今天宣布，欧盟委员会(EC)已延长了现有的ADCETRIS® (brentuximab vedotin)条件性营销授权，并核准ADCETRIS用于治疗自体干细胞移植(ASCT)后复发或进展风险增高的成人CD30+霍奇金淋巴瘤患者。在该决定之前，人用药品委员会于2016年5月26日发表了一项肯定意见。...
View ArticleClik here to view.
One of the World’s Leading Centers for Cardiovascular Medicine &...
NEUCHÂTEL, Switzerland Masimo (NASDAQ: MASI) announced today that Deutsches Herzzentrum Berlin (DHZB / German Heart Center Berlin) in Berlin, Germany, has adopted Masimo’s SedLine® Brain Function...
View ArticleClik here to view.
世界领先的心血管医学及移植中心之一采用Masimo的SedLine®脑功能监护仪和O3™局部氧饱和度仪
瑞士纳沙泰尔 (美国商业资讯) — Masimo (NASDAQ: MASI)今天宣布，德国柏林的德国柏林心脏中心(Deutsches Herzzentrum Berlin, DHZB)已采用Masimo的SedLine®脑功能监护仪和O3™局部氧饱和度仪技术来监护手术室和重症监护病房中的患者。 Smart News Releases（智能新闻稿）是一个多媒体平台。在此处查看完整新闻稿：...
View ArticleClik here to view.
武田薬品、移植後のホジキンリンパ腫に対する地固め療法としてのアドセトリス（ブレンツキシマブ・ベドチン）に関して欧州委員会から承認を取得
米マサチューセッツ州ケンブリッジ & 大阪 （ビジネスワイヤ） — 武田薬品工業株式会社（TSE:...
View ArticleClik here to view.
世界有数の循環器医療／移植センターがマシモのSedLine®脳機能モニタリング技術とO3™リージョナルオキシメトリー技術を採用
スイス・ヌーシャテル （ビジネスワイヤ） — マシモ（NASDAQ: MASI）は本日、独ベルリンのドイツベルリン心臓センター（DHZB）が、手術室と集中治療室で患者をモニタリングするため、マシモのSedLine®脳機能モニタリング技術とO3™リージョナルオキシメトリー技術を採用したと発表しました。 このSmart News...
View ArticleClik here to view.
Presbia to Participate in the 2016 Australasian Society of Cataract and...
DUBLIN Presbia PLC (NASDAQ: LENS), an ophthalmic device company and leader in near-vision restoration, announced that it will participate in the 20th Annual Australasian Society of Cataract and...
View ArticleClik here to view.
First Patient is Randomized in STEMTRA Trial For Traumatic Brain Injury
MOUNTAIN VIEW, Calif. SanBio, Inc., a scientific leader in regenerative medicine for neurological disorders, today announced the randomization of the first patient in the STEMTRA Phase 2 clinical...
View ArticleClik here to view.
投资于癌症治愈方法：GE凭借收购Biosafe Group SA，致力于引领细胞疗法行业的产业化
英格兰CHALFONT ST GILES (美国商业资讯) — GE医疗集团已收购了Biosafe Group SA，后者是面向快速生长细胞疗法和再生医学行业的整合型细胞生物处理系统的提供商，该收购的金额未披露。收购Biosafe可壮大GE医疗集团面向细胞疗法客户的产品、解决方案和服务的端到端生态系统，并将GE的技术触角延伸到若干新的细胞和治疗类别。 Smart News...
View ArticleClik here to view.
Samsung Bioepis’ Marketing Authorization Application for SB5 Adalimumab...
INCHEON, Korea Samsung Bioepis Co., Ltd. today announced that the European Medicines Agency (EMA) has accepted for review the company’s Marketing Authorization Application (MAA) for SB5, a...
View ArticleClik here to view.
Cigna Launches Brand Campaign for International Markets Based on Real Stories...
HONG KONG Cigna has unveiled its first ever regional brand campaign for key international markets, designed to showcase the company’s capabilities and the solutions it delivers for customers. The...
View ArticleClik here to view.
Clik here to view.
Dr. Koshiro Ono of the Japan Automotive Research Institute Honored with Award...
CHICAGO The Association for the Advancement of Automotive Medicine (AAAM), a global, multidisciplinary professional organization dedicated to saving lives and eliminating injuries associated with...
View ArticleClik here to view.
South Korea without Fail Facial Contouring Plastic Surgery Expertise
SEOUL, South Korea With growing popularity with facial contouring surgery, key question is not “how SMALL can you make my face?” but “how PROPORTIONATE can you make my face?”. Refining squarish jaw...
View ArticleClik here to view.
South Korea Plastic Surgery for the Safest Rhinoplasty
SEOUL, South Korea In non-surgical rhinoplasty, originally developed at the turn of the century, early attempts used soft-tissue fillers such as paraffin wax and silicone. The procedure was...
View ArticleClik here to view.
Dr. Oh Has Succeeded in the Research of LASEK on Reduction of Eye Damage
Smart Multimedia Gallery ビデオタイトル QuickTimeで再生 WindowsMediaで再生 SEOUL, South Korea Dr. Oh Jung Woo of EOS eye center released a surprising study that improves the safety of existing vision correction...
View ArticleClik here to view.
G-TACとエムスリー（ソニー関連会社）がCancerIntercept™やBRCATrue®などの遺伝子検査サービスの日本での提供に向けパスウェイ・ゲノ...
東京 （ビジネスワイヤ） — G-TAC Co., Ltd.とエムスリー（ソニーの関連会社）はパスウェイ・ゲノミクスとの戦略的事業提携により、日本における医師2万人以上から成るG-TACのゲノミクスネットワークを通じ、CancerIntercept™、BRCATrue®、PathwayFit®、SkinFit™、その他の遺伝子検査を含む14種類の検査サービスを提供すると発表しました。...
View Article